Vera Therapeutics, Inc.
VERA
$34.25
-$1.03-2.92%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -109.47M | -121.03M | -91.10M | -80.29M | -76.53M |
| Total Depreciation and Amortization | 132.00K | 140.00K | 135.00K | 129.00K | 119.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.53M | 28.12M | 10.61M | 9.57M | 8.23M |
| Change in Net Operating Assets | -6.44M | -13.73M | 10.36M | 8.69M | 13.38M |
| Cash from Operations | -100.25M | -106.50M | -69.99M | -61.91M | -54.80M |
| Capital Expenditure | 0.00 | -23.00K | -102.00K | -133.00K | -208.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.86M | -137.79M | 80.77M | 69.89M | 28.75M |
| Cash from Investing | 32.86M | -137.82M | 80.66M | 69.76M | 28.54M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 23.34M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.92M | 3.94M | 304.19M | 797.00K | 464.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -17.91M | 0.00 | -3.52M |
| Cash from Financing | 1.92M | 3.94M | 286.28M | 797.00K | 20.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.48M | -240.37M | 296.95M | 8.65M | -5.97M |